I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Preference for the fixed-dose combination of pertuzumab and..:
O'Shaughnessy Joyce
;
Sousa Susana
;
Cruz Josefina
...
issn:0959-8049. , 2021
Link:
https://zenodo.org/record/5196150
RT Journal T1
Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study
UL https://suche.suub.uni-bremen.de/peid=base-ftzenodo:oai:zenodo.org:5196150&Exemplar=1&LAN=DE A1 O'Shaughnessy Joyce A1 Sousa Susana A1 Cruz Josefina A1 Fallowefield Lesley A1 Auvinen Paivi A1 Pulido Catarina A1 Cvetanovic Ana A1 Wilks Sharon A1 Ribeiro Leonor A1 Burotto Mauricio A1 Klingbiel Dirk A1 Messeri Dmitri A1 Alexandrou Ari A1 Trask Peter A1 Fredriksson Judy A1 Machackova Zuzana A1 Stamatovic Ljiljana A1 PHranceSCa study group YR 2021 K1 Adjuvant K1 Early breast cancer K1 Fixed dose K1 Healthcare resource K1 Patient preference K1 Patient-reported outcomes K1 Pertuzumab K1 Quality of life K1 Subcutaneous K1 Trastuzumab JF issn:0959-8049 LK http://dx.doi.org/https://zenodo.org/record/5196150 DO https://zenodo.org/record/5196150 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)